PFE Financial Facts
Basic (in shares): 6.07BIncome from continuing operations: 1.32B
See Full Income Statement
Inventories: 7.51B
Accrued compensation and related items: 2.05B
See Full Balance Sheet
Pfizer Inc. (PFE) Earnings
|
Expand Research on PFE
Next EPS Date | 5/1/24 | EPS Growth Rate | -56.1% |
---|---|---|---|
Average EPS % Beat Rate | +21.5% | Revenue Growth Rate | -22.7% |
Average % Move 1-Wk after EPS | -0.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
7/28/22 | Q222 | $2.04 | $1.71 | +$0.33 | $27.7B | $25.26B | = | Details | |||
1/31/23 | Q422 | $1.14 | $1.07 | +$0.07 | $24.29B | $24.61B | = | Details | |||
2/8/22 | Q421 | $1.08 | $0.88 | +$0.20 | $23.8B | $24.17B | = | Details | |||
5/3/22 | Q122 | $1.62 | $1.47 | +$0.15 | $25.7B | $23.86B | = | Details | |||
11/2/21 | Q321 | $1.37 | $1.08 | +$0.29 | $24.1B | $22.68B | Details | ||||
11/1/22 | Q322 | $1.78 | $1.44 | +$0.34 | $22.6B | $21.33B | = | Details | |||
7/28/21 | Q221 | $1.07 | $0.96 | +$0.11 | $19B | $18.45B | Details | ||||
8/2/11 | Q211 | $0.60 | $0.59 | +$0.01 | $16.98B | $16.98B | = | Details |